Spire Healthcare Group (LON:SPI) Sets New 1-Year Low – Time to Sell?

Posted by Stacy Sanders on Mar 10th, 2025

Spire Healthcare Group plc (LON:SPI – Get Free Report) reached a new 52-week low during trading on Monday . The company traded as low as GBX 168.20 ($2.17) and last traded at GBX 173.40 ($2.24), with a volume of 1417725 shares trading hands. The stock had previously closed at GBX 177.20 ($2.29).

Analyst Upgrades and Downgrades

Separately, Deutsche Bank Aktiengesellschaft decreased their price target on Spire Healthcare Group from GBX 320 ($4.14) to GBX 300 ($3.88) and set a “buy” rating for the company in a research note on Thursday.

View Our Latest Analysis on SPI

Spire Healthcare Group Stock Performance

The company’s 50-day moving average price is GBX 227.28 and its two-hundred day moving average price is GBX 229.38. The company has a market capitalization of £696.32 million, a price-to-earnings ratio of 24.68, a PEG ratio of 1.06 and a beta of 0.96. The company has a debt-to-equity ratio of 62.25, a current ratio of 0.70 and a quick ratio of 0.74.

Spire Healthcare Group (LON:SPI – Get Free Report) last issued its quarterly earnings results on Thursday, March 6th. The company reported GBX 8.80 ($0.11) earnings per share for the quarter. Spire Healthcare Group had a return on equity of 3.82% and a net margin of 1.96%. On average, equities research analysts anticipate that Spire Healthcare Group plc will post 15.6634747 EPS for the current fiscal year.

About Spire Healthcare Group

(Get Free Report)

Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments.